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REVIEW ARTICLE

Imaging Guided Breast Interventions
ABSTRACT

Imrana Masroor, Shaista Afzal and Saira Naz Sufian

Breast imaging is a developing field, with new and upcoming innovations, decreasing the morbidity and mortality related
to breast pathologies with main emphasis on breast cancer. Breast imaging has an essential role in the detection and
management of breast disease. It includes a multimodality approach, i.e. mammography, ultrasound, magnetic resonance
imaging, nuclear medicine techniques and interventional procedures, done for the diagnosis and definitive management
of breast abnormalities. The range of methods to perform biopsy of a suspicious breast lesion found on imaging has also
increased markedly from the 1990s with hi-technological progress in surgical as well as percutaneous breast biopsy
methods. The image guided percutaneous breast biopsy procedures cause minimal breast scarring, save time, and relieve
the patient of the anxiety of going to the operation theatre. The aim of this review was to describe and discuss the different
image guided breast biopsy techniques presently employed along with the indications, contraindication, merits and
demerits of each method.
Key Words: Breast cancer. Percutaneous biopsy. Breast imaging.

INTRODUCTION

Breast screening by mammography has increased
awareness of breast cancer, which is the second most
common cause of death in females.1 Screening
mammography has led to increased discovery of
localized breast cancer and has resulted in increase in
number of biopsies with majority being performed under
imaging guidance.2 The resultant diagnosis finally leads
to early and appropriate patient care and subsequent
neoadjuvant and surgical treatment in case of
malignancy.3 The image guided percutaneous breast
biopsy procedures are minimally invasive, cause less
breast scarring, save time and money, and relieve the
patient of the anxiety of going to the operation theatre.4
Majority, i.e. 70 - 80% of image detected suspicious
breast lesions biopsied under image guidance turn out to
be benign thus obviating a need for a surgical
procedure.5 In addition, patients who are diagnosed as
having cancer undergo fewer operations as the disease
is detected at a non-clinical earlier stage.6,7 Masroor
et al. studied the cost effectiveness of percutaneous
breast biopsy to open surgical biopsies, and reported
that the cost saving per patient was 253 US dollars.8
Similarly, other studies reported that core needle biopsy,
in comparison to open surgical biopsy, lead to cost
saving from 51 to 96%.9,10 Image guided vacuumassisted core biopsy yields a high diagnostic accuracy
predominantly of lesions with low to intermediate risk of
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malignancy. Approximately half of the cases obviate the
need for surgical removal with resultant better cosmetic
result.11

The National Comprehensive Cancer Network (NCCN),
in the most recent Clinical Practice Guidelines, has
recommended percutaneous breast biopsy for lesions
categorised as Breast Imaging Reporting and Data
System (BI-RADS) 4 (suspicious abnormality); or
BI-RADS 5 ( highly suggestive of malignancy).12

Indeed, breast program accrediting bodies recommend
image guided biopsy as the standard of care, and
recommend this as one of the measures of quality when
accrediting breast imaging centres.

A number of institutions in Pakistan are at present in the
phase of setting up sections of breast imaging and
intervention; and are faced with the challenges of learning
how to perform image guided breast interventions. The
options available for such interventions and the
appropriate modality for image guidance are not widely
known among many clinicians.
The objective of this review was to describe and discuss
the different aspects of image guided biopsy techniques
along with the authors’ practices, their indications and
contraindication along with their merits and demerits.

METHODOLOGY

Studies published in English language from 2000 to
2015 were searched by using key words “ultrasound
guided biopsy, stereo-tactic biopsy, needle localization,
MRI guided biopsy and sampling techniques” on
PubMed, Medline and Google Scholar. Relevant
publications describing the localizing and sampling
techniques of breast lesions under various imaging
modalities along with their technical aspects, cost
efficacy and merits and demerits, were included. Overall
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56 studies were selected after analysing and evaluating
the papers. Historical details were collected from the
older reviews. Results were described as localizing and
sampling techniques.

Localizing techniques: The localization of suspicious
breast lesions is performed under ultrasound, stereotactic and MRI guidance with ultrasound being the most
commonly employed.

Ultrasound: Presently, ultrasound is being increasingly
used for breast interventions which may be diagnostic
like percutaneous biopsy of breast lesions/axillary
lymphadenopathy and preoperative wire localization or
therapeutic like cyst aspirations and abscess drainage.
The ultrasound guided core needle biopsy is now the
preferred method for performing most breast biopsies
with sensitivity of 97.5%.13

Figure 1: Ultrasound guidance for core needle biopsy. (A) Measurement of
lesion. (B) Echogenic needle seen within the lesion.

The advantages of ultrasound-guided biopsy are: short
duration of the procedure, less discomfort, better
tolerated by the patient, reduced cost, low risk of
infection, high yield of accurate samples as the
procedure is performed in real time, and lastly since this
requires no radiation exposure or intravenous (IV)
contrast, it is the localizing technique of choice in
pregnant patients.14,15 This localizing technique is cost
effective in comparison to biopsies under stereotactic
guidance.16,17
The equipment required for ultrasound-guided breast
interventions are high frequency transducer and biopsy
device.

Micro-calcifications detected on ultrasound in addition to
mammography are more often malignant18 and can also
be sampled using ultrasound, especially under circumstances when stereotactic biopsy is not feasible, e.g. due
to limitations of patient positioning or breast size. The
contraindications to ultrasound-guided breast biopsy
include non-visualization of lesion sonographically, uncooperative patient etc.13
For the procedure, the patient is comfortably positioned.
Under ultrasound guidance and after usual preparation,
the needle is advanced and inserted into the lesion and
the required number of samples are obtained, (Figure 1)
documenting the needle placement in 2 orthogonal
planes.

Stereotactic guidance: The number of women
diagnosed with ductal carcinoma in situ (DCIS) has
increased in the past few years as a result of screening
mammography. The commonest mammographic feature
of DCIS is micro-calcification, which is conveniently
sampled with stereotactic biopsy.19 The accuracy of
stereotactic biopsy instrument is influenced by the
sampling technique, i.e. core needle biopsy (CNB)
versus vacuum assisted biopsy (VAB) with increasing
accuracy ranging from 87% to 97% when larger samples
are obtained. False negative rate being 1.2 - 5.4%.20
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Figure 2: (A) Mammography unit with add-on stereotactic device. (B) Stereo
images.

The stereotactic devices were added on to the standard
mammography units at its inception with the patient in
upright sitting position (Figure 2). Prone biopsy units
were introduced in mid-1980's with the patient lying
prone for the procedure. This reduced patient
movement, improved patient comfort, and eliminated
syncope in addition to enabling the biopsy of lesions
close to the chest wall due to the gravitational
influence.21
When micro-calcifications are sampled, the specimen
radiography is performed to confirm the presence of
representative calcifications. A minimum 3 flecks of
calcification should be present in at least 2 cores and, if
possible, 5 or more flecks in 3 cores.22
For the procedure, initially scout images are achieved to
confirm the presence of suspicious calcifications or
lesion in the biopsy region, following which stereoimages are obtained (Figure 2). The coordinates of the
final 3 dimensions are derived by triangulation formulas
making sure the presence of adequate stroke margin to
avoid damage to the biopsy apparatus.
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Figure 3: Needle localization of micro-calcifications and specimen
radiography showing clustered micro-calcifications.

Figure 4 (A,B,C): (A) Left breast lump, that was subjected to ultrasound
guided core biopsy and clip placement. (B) Post neoadjuvant chemotherapy
mammography shows significant reduction in size of the lesion. (C) Needle
localization of metallic clip under stereotactic guidance.

The breast is cleansed and draped to achieve asepsis;
and under local anaesthesia, biopsy is performed after
confirming accurate needle placement followed by
specimen radiography, if suspicious calcifications were
targeted. Radio opaque markers/clips are placed to
mark the position of the biopsy site.21

The complication rates of stereotactic biopsy are low
and include minimal pain, bruising, formation of
hematoma and abscess with 0.1% requiring surgical
drainage21 and seeding of tumour cells which does not
appears to be of clinical implication.23 Communication
with the patients and educating them regarding these
complications before the procedure, helps diminish
patients’ apprehension and anticipated pain.24

One of the limitations of the stereotactic biopsy is nonapplicability in a thin or small breast, as adequate breast
thickness is not available while in compression. For
patients weighing more than 300 pounds, prone table
cannot be used due to weight restrictions from most
vendors. Another important limitation is related to the
gauge of the biopsy device, i.e. CNB/VAC which may
result in the upgrading of DCIS on definitive surgery.25

Magnetic resonance imaging (MRI): Due to the proven
sensitivity and specificity of contrast enhanced MRI for
the detection of breast lesions, especially those not
detected on other imaging modalities,26 there is a
resultant increase in demand for its utility in obtaining
samples for histological evaluation.27 Once a lesion is
categorized as BI-RADS 4 or 5 and only seen on MRI,
then this warrants re-examination of mammograms and
targeted ultrasound, i.e. second look to evaluate for a
correlate. If initially obscured findings are visible on relook mammography or ultrasound, then the MRI
detected lesions should be biopsied under ultrasound or
mammographic guidance. Up to 57% of lesions detected
only on MRI can be sonographically correlated and
hence biopsied.28 MRI guided biopsy is recommended
only if no correlate detected on second-look ultrasound.

The MRI guided biopsy is technically more complex,
costly, and time consuming due to reasons like the
availability of MRI compatible biopsy device and patient
to be moved in and out of the magnet bore during the
procedure. After obtaining localization images,
intravenous contrast is administered to locate suspicious
lesion. Computerized calculations aid in determining the
precise location of the lesion in relation to the grid.
A co-axial technique is used for most MRI guided
biopsies using MRI compatible needles (i.e. titanium).29
The limitation is the difficulty in localization of small
lesions and that of time since the breast parenchyma
shows gradual increase in enhancement, which may
obscure the suspicious lesion with rapid contrast
washout. The general limitations of MRI like
claustrophobia and patient body habitus also apply for
this procedure.
Sampling Techniques:

Fine needle aspiration (FNA): The technique is
essentially unchanged since its inception in the 1930's.30

This procedure diagnoses the breast lesions with high
accuracy (72 - 94%), although it depends on operator's
skill and experience.31-33 It has a miss-rate of 5%,34
requiring a repeat biopsy or further investigation.32

FNA being minimally invasive and cost effective35 was
the most widely used technique for breast biopsy before
the 1990s, but it had many limitations like operator
dependency, non-availability of skilled cytopathologist
for rapid interpretation of results at many centres. Thus
making rapid evaluation impossible.36 The pathologist
can only report benign or malignant cells in the aspirate
and cannot comment on in situ or invasive carcinoma or
on hormone receptor status.37 The advantages of CNB
has led to overall decrease in its utilization.38 FNA is still
invaluable for the evaluation of axillary lymph nodes or
lesions adjacent to breast implants or lesions near
pectoral muscles which are very close to chest wall.33
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The technique involves utilization of aseptic technique
and under ultrasound guidance 19 to 25-G needles are
used. For maximum safety of the underlying structures,
the needle is inserted at a shallow angle achieved by
selecting the entry site of needle at a distance of 1 - 2 cm
from the transducer.39 In most instances, 2 passes into
the lesion at different angles and with moderate suction
are sufficient. The radiologist prepares the smears from
the aspirate by fixing in alcohol for Papanicolaou and
Diff-Quik stain and preliminary diagnosis is provided by
the on-site cytopathologist.

Core needle biopsy (CNB): A growing use of CNB
technique was witnessed in the 1990's on account of
adequacy of sample and hence accurate differentiation
of benign from malignant lesion.40

After the identification of the lesion, the overlying skin is
marked, cleansed and local anaesthesia is injected.
A skin incision is given to allow insertion of core needle
device in a spring loaded automated gun. Usually a
14-gauge needle is used.41 The biopsy gun retrieves
small cores of tissue, thus allowing more adequate
histological evaluation. Micro-calcifications require more
cores than solid lesions.37-39 The needle is directed into
the lesion parallel to chest wall in order to avoid damage
to chest wall structures. After adequate samples have
been taken, pressure is applied at biopsy site. Postprocedure specimen radiography is done, especially if
the biopsy was done for suspicious micro-calcifications
seen on mammogram. It is recommended to obtain a
minimum of 4 non-fragmented specimens to enhance
the yield of the procedure under ultrasound guidance.42
A major limitation of CNB is under estimation of disease,
such as with atypical ductal hyperplasia (ADH) and
ductal carcinoma in situ (DCIS).43

The miss-rate for core needle biopsy has been reported
as 8 - 12% and the under estimation rates of 3.4% to
100% have been reported.37

Vacuum-assisted breast biopsy (VABB): The
limitations of core biopsies lead to development of VABB
in the late 1995.44 The initial technique has potentially
reduced the under-estimation and false negative rates. It
is same as CNB and under imaging guidance single
insertion of an 8 or 11 gauge needle facilitates faster
retrieval of large tissue volumes in contiguous
specimens of tissue. VABB with an 11-G needle can be
employed for complete resection of lesions that are
1.0 cm or less in diameter and an 8-gauge needle is
capable of resecting breast lesions less than 3.0 cm in
diameter.45 It is associated with complications like pain
and haemorrhage but offers acceptable cosmetic
outcome.46 The histopathological diagnosis after VABB
is known to be reliable and almost equivalent to open
surgical biopsy, as quoted in some studies.47
Surgical excision following needle localization: The
procedure is performed under image guidance, i.e.
524

mammography, ultrasound, and MRI. After the usual
preparation, a hook-wire is placed inside a rigid
introducer needle and advanced into the suspicious
lesion; and once its location within the lesion is
confirmed, the needle is taken out and the hook wire is
left in place. The hook wire is self-retaining and anchors
to the tissue which prevents further advancement,
withdrawal, and movement (Figure 3).48

Mammographic images are provided to the surgeon and
the radiologist describes the lesion location in relation to
the wire. Specimen imaging should be obtained to verify
the removal of suspicious lesions/calcifications (Figure 3).

A working alliance among an experienced surgeon,
radiologist and pathologist is crucial to achieve desired
surgical results. Needle localization followed by open
surgical biopsy provides an opportunity for rapid and
precise excision resulting in minimal tissue damage49
with low miss-rates (-1.1%) and false negative rates
(1.0%).50 The open surgical biopsy for initial diagnosis is
an invasive test, hence it is not recommended by NCCN
as an initial procedure.

Radio-opaque metallic marker/clip placement:
Radio-opaque metallic markers/clips are placed after
image guided biopsy in almost all cases, and
mammograms obtained to confirm its position. A single
clip should ideally be placed in the center of the lesion.
It localizes the tumor bed with radio-opaque markers
prior to the institution of chemotherapy and facilitates
breast conservation surgery with excision of entire tumor
bed even after complete clinical and radiological
response (Figure 4).51,52 The marker is also placed
after biopsy of non-palpable or too small breast lesion
with possibility of complete disappearance after
biopsy.53 Post-deployment clip migration is a common
complication associated with this procedure and may be
seen immediately after the biopsy or on follow-up
mammography.54 There are 3 categories of clip markers,
i.e. commercial metallic markers, which include stainless
steel and plain titanium clips, metallic markers covered
with bio-absorbable substance, and markers that can be
locally assembled by using the Montreal technique.55,56

CONCLUSION

Percutaneous imaging guided biopsy can provide a
diagnosis with minimum patient trauma as it is minimally
invasive and also saves time. It provides an opportunity
to the breast surgeon to discuss with the patient the
surgical options, based on the histopathology results. A
multi-modality approach, i.e. mammography, ultrasound,
and magnetic resonance imaging can be utilized for
optimum patient care and accurate diagnosis.
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